TrialApoptosis : an international journal on programmed cell death2011

XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML.

Bing Z Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.